InnovaRx Innova Health Strategies

L68.9

Hypertrichosis, unspecified

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 5 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 13 never code together
L68code
Excludes1
  • congenital hypertrichosis (Q84.2)Q84.2
  • persistent lanugo (Q84.2)Q84.2
L60-L75block
Excludes1
  • congenital malformations of integument (Q84.-)Q84.-
L00-L99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • lipomelanotic reticulosis (I89.8)I89.8
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
  • systemic connective tissue disorders (M30-M36)M30-M36
  • viral warts (B07.-)B07.-

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 1
L68code
Includes
  • excess hair
Index entries leading here 1
Alongside this code 5 same parent — L68
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
L68
Block
L60-L75
Siblings
5

Present FY2024–FY2027.